320 filings
S-3
SKYE
Skye Bioscience Inc
Shelf registration
10 May 24
4:19pm
S-3
SKYE
Skye Bioscience Inc
Shelf registration
10 May 24
4:17pm
10-Q
2024 Q1
SKYE
Skye Bioscience Inc
Quarterly report
10 May 24
4:02pm
EFFECT
SKYE
Skye Bioscience Inc
29 Apr 24
Notice of effectiveness
12:15am
POS AM
SKYE
Skye Bioscience Inc
24 Apr 24
Prospectus update (post-effective amendment)
4:40pm
EFFECT
7xrgtzx93g9 e9ln41yb
11 Apr 24
Notice of effectiveness
12:15am
424B3
ppa2g2
10 Apr 24
Prospectus supplement
4:40pm
CERT
2xhwa 9ox
10 Apr 24
Certification of approval for exchange listing
9:58am
8-A12B
cse ibdo6u
10 Apr 24
Registration of securities on exchange
7:00am
8-K
9kabgvxtovx0i434i
3 Apr 24
Regulation FD Disclosure
5:07pm
D
46t8rj 39ooz
26 Mar 24
$40.00 mm in equity, sold $40.00 mm, 13 investors
6:04pm
8-K
o7eb5x
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
x740 ojouunw7xfc
4 Mar 24
Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
4:23pm
8-K
zw5j4q9l 38nhb64
12 Feb 24
Other Events
4:18pm
D
3td2c t3ay5et5uk
12 Feb 24
$49.99 mm in equity / options, sold $49.99 mm, 11 investors
12:08pm
8-K
nmc6 hbhk5j43jaaif
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
S-8
mut 2ny32zj5us5dpzay
21 Dec 23
Registration of securities for employees
7:07pm